Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma

Cancer

Volumn 119, Issue 6, 2013, Pages 1159-1167

  Tanaka, Youhei ^a   Kamohara, Hidenobu ^a   Kinoshita, Kouichi ^a   Kurashige, Junji ^a   Ishimoto, Takatsugu ^a   Iwatsuki, Masaaki ^a   Watanabe, Masayuki ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

esophageal cancer; exosome; human microRNA 21; microRNA

Indexed keywords

C REACTIVE PROTEIN; MICRORNA 21; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXOSOME; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; RNA PURIFICATION; TUMOR CLASSIFICATION; TUMOR GROWTH; UPREGULATION;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; EXOSOMES; FEMALE; HUMANS; INFLAMMATION; MALE; MICRORNAS; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84874755851     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27895     Document Type: Article

References (36)

1. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E,. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005; 120: 21-24.
2. Pillai RS,. MicroRNA function: multiple mechanisms for a tiny RNA? RNA. 2005; 11: 1753-1761.
3. Zamore PD, Haley B,. Ribo-gnome: the big world of small RNAs. Science. 2005; 309: 1519-1524.
4. Chen CZ, Li L, Lodish HF, Bartel DP,. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004; 303: 83-86.
5. Croce CM, Calin GA,. miRNAs, cancer, and stem cell division. Cell. 2005; 122: 6-7.
6. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6: 857-866.
7. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18: 997-1006.
8. Filipowicz W, Bhattacharyya SN, Sonenberg N,. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9: 102-114.
9. Clayton A, Court J, Navabi H, et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods. 2001; 247: 163-174.
10. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C,. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987; 262: 9412-9420.
11. Thery C, Zitvogel L, Amigorena S,. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2: 569-579.
12. Trams EG, Lauter CJ, Salem N, Jr, Heine U,. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 1981; 645: 63-70.
13. Wolfers J, Lozier A, Raposo G, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001; 7: 297-303.
14. Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001; 166: 7309-7318.
15. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO,. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654-659.
16. Quesenberry PJ, Aliotta JM,. The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev. 2008; 4: 137-147.
17. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ,. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia. 2006; 20: 1487-1495.
18. Hiyoshi Y, Kamohara H, Karashima R, et al. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res. 2009; 15: 1915-1922.
19. Kurashige J, Kamohara H, Watanabe M, et al. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J Surg Oncol. 2012; 106: 188-192.
20. Kroh EM, Parkin RK, Mitchell PS, Tewari M,. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010; 50: 298-301.
21. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH,. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10: 42-46.
22. Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470-1476.
23. Taylor DD, Gercel-Taylor C,. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13-21.
24. Thery C,. Exosomes: secreted vesicles and intercellular communications [serial online]. F1000 Biol Rep. 2011; 3: 15.
25. Gallo A, Tandon M, Alevizos I, Illei GG,. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes [serial online]. PLoS One. 2012; 7: e30679.
26. Michael A, Bajracharya SD, Yuen PS, et al. Exosomes from human saliva as a source of microRNA biomarkers. Oral Dis. 2010; 16: 34-38.
27. Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line [serial online]. PLoS One. 2010; 5: e13247.
28. Taylor DD, Zacharias W, Gercel-Tayler C,. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol. 2011; 728: 235-246.
29. Nielsen BS, Jorgensen S, Fog JU, et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis. 2011; 28: 27-38.
30. Jiang J, Gusev Y, Aderca I, et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res. 2008; 14: 419-427.
31. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M,. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008; 12: 2171-2176.
32. Nam EJ, Yoon H, Kim SW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008; 14: 2690-2695.
33. Li T, Li RS, Li YH, et al. MiR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer. J Urology. 2012; 187: 1466-1472.
34. Qu JL, Qu XJ, Zhao MF, et al. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis. 2009; 41: 875-880.
35. Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes [serial online]. PLoS One. 2012; 7: e30679.
36. Zhang HL, Yang LF, Zhu Y, et al. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy. Prostate. 2011; 71: 326-331.